Kondás J, Philipp V, Diószeghy G
Department of Urological Surgery, Municipal Péterfy Sándor Street Hospital, Budapest, Hungary.
Int Urol Nephrol. 1996;28(6):767-72. doi: 10.1007/BF02550725.
The effectivity of Sabal serrulata extract in the treatment of symptomatic prostatic hyperplasia was scrutinized in 38 patients. In the course of the 12-month treatment followed up by examinations, the subjective complaints abated in almost 3/4 of the cases. Adverse effects were not encountered. According to uroflowmetry, the average peak flow rate increased from 10.36 ml/s to 14.44 ml/s (p < 0.0001), while the average middle stream increased from 6.02 ml/s to 7.45 ml/s (p < 0.001). Urinary retention decreased or disappeared in more than 9/10 of the cases. The average amount of the residue decreased by 47 ml (p < 0.001). The average volume of the prostate was reduced by 10.6% (p < 0.02). On the basis of the favourable results, Sabal serrulata extract is recommended in the treatment of prostatic hyperplasia producing symptoms of mild and moderate severity.
对38例患者研究了锯叶棕提取物治疗有症状前列腺增生的有效性。在为期12个月的治疗过程中，经过检查随访，近3/4的病例主观症状减轻。未发现不良反应。根据尿流率测定，平均最大尿流率从10.36毫升/秒增至14.44毫升/秒（p<0.0001），而平均尿流率从6.02毫升/秒增至7.45毫升/秒（p<0.001）。超过9/10的病例尿潴留减轻或消失。残余尿量平均减少47毫升（p<0.001）。前列腺平均体积缩小10.6%（p<0.02）。基于这些良好结果，推荐锯叶棕提取物用于治疗产生轻、中度症状的前列腺增生。
